Jennison Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-257,939	Closed	-$37.8M	–	726
2021 Q4	$37.8M	Sell	257,939 -4,382	-2%	-$680K	0.02%	269
2021 Q3	$46.4M	Buy	262,321 +89,329	+52%	+$14.4M	0.03%	232
2021 Q2	$27.9M	Buy	172,992 +89,395	+107%	+$14.4M	0.02%	324
2021 Q1	$14.3M	Buy	+83,597	New	+$16.6M	0.01%	389
2020 Q3	–	Sell	-504,451	Closed	-$57.6M	–	703
2020 Q2	$57.6M	Sell	504,451 -78,468	-13%	-$7.61M	0.05%	147
2020 Q1	$44.8M	Sell	582,919 -4,768	-0.8%	-$428K	0.05%	156
2019 Q4	$75.7M	Sell	587,687 -132,714	-18%	-$12.8M	0.08%	142
2019 Q3	$56.1M	Sell	720,401 -246,930	-26%	-$23.2M	0.06%	179
2019 Q2	$99.6M	Sell	967,331 -225,348	-19%	-$17.5M	0.1%	118
2019 Q1	$87.4M	Sell	1,192,679 -23,785	-2%	-$1.62M	0.09%	133
2018 Q4	$51.6M	Buy	1,216,464 +217,960	+22%	+$8.69M	0.06%	202
2018 Q3	$47M	Buy	998,504 +383,785	+62%	+$21.4M	0.04%	262
2018 Q2	$30.3M	Buy	614,719 +86,323	+16%	+$3.26M	0.03%	342
2018 Q1	$16.2M	Buy	528,396 +40,797	+8%	+$1.13M	0.02%	416
2017 Q4	$8.9M	Buy	+487,599	New	+$7.57M	0.01%	470
2016 Q2	–	Sell	-65,789	Closed	-$1.41M	–	670
2016 Q1	$1.41M	Buy	65,789 +535	+0.8%	+$12K	﹤0.01%	546
2015 Q4	$2.06M	Buy	65,254 +254	+0.4%	+$8.97K	﹤0.01%	559
2015 Q3	$2.24M	Buy	+65,000	New	+$1.96M	﹤0.01%	591

Other funds holding MRTX